Delivery Order SPE2DB22D1017-SPE2DB25FYSBF
- Not listed
- The Defense Logistics Agency awarded a $1,211.75 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens. This firm fixed price, non-competitive delivery order was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The order was fulfilled at the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a $2,491.38 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/mL 3mL insulin pens on May 6, 2025, with completion scheduled for May 7, 2025. This competitively awarded, firm fixed-price contract represents a small-value pharmaceutical procurement with no set-aside designation. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $2,076.30 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.59 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This was a competitively awarded, non-set-aside firm fixed price contract with an ultimate completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Tresiba FlexTouch 100 unit/mL insulin pens in 3mL quantities. This $2,146.80 firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $19,847.95 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens on June 25, 2025, with completion expected by June 26, 2025. This is a firm fixed price, non-set-aside contract that will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies critical medications and medical products to support military and federal...
- The Defense Logistics Agency awarded a $4,222.74 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/ml insulin pens (3ml). This contract, awarded on July 21, 2025, represents a firm fixed-price procurement with an ultimate completion date of July 22, 2025. The award was not set-aside and was competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at...
- The Defense Logistics Agency awarded a delivery order valued at $1,038.15 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This competitive award, issued on September 29, 2025, with an ultimate completion date of September 30, 2025, represents a firm fixed price transaction for pharmaceutical supply to support federal medical procurement needs. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.30 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This competitively awarded, firm fixed-price delivery order was issued on April 30, 2025, with an ultimate completion date of May 1, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters and serves as a major vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at approximately $74,717 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes a firm fixed price structure and carries no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSBFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for $2,491.38 to supply Tresiba FlexTouch 200 unit/mL 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor vehicle enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems worldwide. The company's extensive contract portfolio with DLA demonstrates its critical role in supporting Defense Health Agency operations and other government healthcare programs across multiple therapeutic domains, including diabetes management, specialty medications, and general pharmaceutical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/26/25 |